32nd Congress of the ESP and XXXIII International Congress of the IAP
Glasgow 2020: A Vision for the Future
29 August – 2 September 2020 | Glasgow, UK
ESP website
32nd ESP Congress & XXXIII IAP Congress in Glasgow
Congress
ECP 2019 Nice
Presentations
Wednesday, 11 September 2019
Congress
Welcome Address
General Information
Welcome to Glasgow
Downloads
Related Meetings / Media Partners
Committees & Organiser
CME Accreditation
Congress Newsletter
ECP 2019 Nice
Gallery
Awardees
Industry Partners
Presentations
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Abstracts
Guidelines for Submission
Bursaries
Format Descriptions
Best Oral and Poster Prizes
Registration & Hotels
Registration Fees
Group Registration
Accommodation
Online Registration
Scientific Programme
Scientific Contents
Sponsors & Exhibitors
General Information
My Account
Create Account
Congress Account
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Wednesday, 11 September 2019
08:30 - 12:00
SC-11 | Joint Session Cytopathology / Ophthalmic Pathology: From the eyes to the brain
SC-11-001-The use of cellient procedure for small tissue particles in cytology
SC-11-003-Aqueous/vitreous (uveitis vs lymphoma tumours) cytology
SC-11-004-The role of cytology in the diagnosis of ophthalmic lesions of the eyelid, conjunctiva and cornea
SC-11-005-CSF cytology
SPEC-04 | Special Session ESP & IAP: The case I will never forget
SPEC-04-002-Case 2
SPEC-04-005-Case 5
SPEC-04-006-Case 6
SPEC-05 | Taskforce Synoptic Reporting & ICCR: Synoptic reporting: to the next level
SPEC-05-001-Where are we going in 2020: update from the ICCR
SPEC-05-002-Not lost in translation!
SPEC-05-004-Molecular data in synoptic reports, part I: Canada
SPEC-05-005-Molecular data in synoptic reports, part II: the Netherlands
SS-13 | Joint Session Molecular Pathology and Trainees: Next generation pathology
SS-13-002-Case 1
SS-13-004-Case 3
SS-13-005-Case 4
SS-13-006-Case 5
SS-13-007-Case 6
SS-13-009-Case 8
SS-13-010-Case 9
SS-13-011-Case 10
SY-23 | Joint Session Uropathology & ESUP: An update on pathologic features of prostate and kidney carcinomas
SY-23-002-Novel and emerging pink (eosinophilic) renal tumours
SY-23-003-Cystic renal cell carcinoma in pathology practice
SY-23-004-Intra-operative assessment of RP surgical margins: the patients’ and pathologists’ view
SY-23-006-Molecular taxonomy of bladder cancer. Current status
SY-23-005-Molecular alterations for a molecular tumour board for prostate cancer patients
SY-24 | Joint Session Digestive Diseases Pathology & UEG: Challenging issues of post-treatment conditions in GI cancer pathology
SY-24-001-Endoscopic resection of gastrointestinal lesions and clinically challenging post-treatment conditions
SY-24-003-The wide range of drug related changes seen in gastrointestinal biopsies
SY-24-004-Current state and future perspectives of neoadjuvant treatment of gastrointestinal carcinomas
SY-24-005-Tumour regression grading - anything new?
SY-25 | Cardiovascular Pathology: Integrated morphologic and molecular approach to diagnosis of cardiovascular disease
SY-25-002-Pathology and genetics of Phospholamban cardiomyopathy
SY-25-003-Cardiomyopathies in neuromuscular disease
SY-25-004-Familial aortic dissection
SY-26 | History of Pathology: Colours of pathology: from H&E to molecular testing (+Business Meeting)
SY-26-001-Two hand in hand lovers on a glassy path: haematoxylin and eosin and histology
SY-26-004-Immunohistology: a historical perspective
14:00 - 16:00
SC-12 | Joint Session Cardiovascular Pathology / Autopsy Pathology: Autopsy investigations on the operated heart & vessels
SC-12-004-End stage heart disease: pathology of cardiac assist and replacement
SPEC-06 | Joint Session Papanicolaou Society of Cytology and French Society of Clinical Cytology: From morphology to the ancillary techniques and molecular cytopathology
SPEC-06-001-Head and neck cytology specimens: HPV testing and p16 staining
SPEC-06-002-Salivary glands cytology: morphology, FISH and NGS
SPEC-06-004-Effusions: morphology, immunocytochemistry and molecular cytopathology
SPEC-06-005-Pancreaticobiliary cytology: morphology, FISH and NGS
SPEC-07 | Pathology & Public Task Force: Pathology and public
SPEC-07-001-Pathology and EU affairs: the formalin ban case
SPEC-07-002-Students' perception of pathology in everyday medical practice
SPEC-07-003-Pathology and Public: the perspective of a resident
SPEC-07-004-Pathology and Public: what a pathologist can do!
SPEC-07-005-Pathology without frontiers: the human face of pathology
SPEC-07-006-Science and art through the microscope
SPEC-07-007-Pathology and Public Task Force: can we do better?
SS-14 | Joint Session Soft Tissue and Bone Pathology / Ophthalmic Pathology: More than meets the eyes
SS-14-001-Case 1
SS-14-002-Case 2
SS-14-003-Case 3
SS-14-004-Case 4
SS-14-005-Case 5
SS-14-006-Case 6
SS-14-007-Case 7
SY-27 | Joint Session Endocrine Pathology / Uropathology: Update on endocrine/neuroendocrine neoplasms of the adrenal gland and urogenital system
SY-27-001-Similarity and differences among neuroendocrine tumours of the kidney
SY-27-002-Neuroendocrine tumours of the prostate: from morphology to molecular perspective
SY-27-003-The spectrum of neuroendocrine neoplasms of the urinary bladder
SY-27-004-New diagnostic guidelines for adrenocortical carcinoma
SY-27-005-Sporadic and familial pheochromocytoma: an update
SY-28 | Digestive Diseases Pathology: Immune-related hepato-biliary and pancreatic disorders: Update of old classifications and new disease entities
SY-28-002-Drug-related liver injury due to immunocheckpoint inhibitors and drugs used in the therapy of autoimmune hepatitis
SY-28-004-Autoimmune pancreatitis
SY-29 | National Societies: (Re)certification in pathology - a reality or an illusion?
SY-29-002-Talk 2
SY-29-003-Talk 3
SY-29-004-Talk 4
SY-29-005-Talk 5
SY-29-006-Talk 6
SY-29-007-Talk 7
SY-29-008-Talk 8
SY-30 | Joint Session Pathology in Favour of Developing Countries / History of Pathology / Infectious Diseases Pathology: Pathology of migration or migration of pathologies?
SY-30-001-Introduction to the session by ESP President
SY-30-002-When migrants were Europeans: a lesson to remember from the past
SY-30-003-Mines and illness: the price to pay for raw materials
SY-30-004-The role of communicable diseases in present migrations
TR-01 | Trainees' Session: Residencies across Europe: realities, problems and future perspectives
TR-01-001-UEMS activity, EU Pathology training requirements, and EU Board of Pathology
TR-01-002-Molecular pathology in the Polish residency: realities, problems and future perspectives
TR-01-003-The ESP/UEMS pathology progress test: how does it contribute to harmonisation of training outcome?
TR-01-004-The residency in Spain: realities, problems and future perspectives
TR-01-005-The Dutch model
TR-01-006-The residency in the Netherlands: realities, problems and future perspectives
TR-01-007-The role of sub-specialisation in the training of pathology in Europe
TR-01-008-The residency in France: realities, problems and future perspectives
TR-01-010-The current state of post-graduate training in Europe: data from a survey with a review of the literature
16:30 - 17:15
KL-04 | Keynote Lecture by Pierre Bedossa
KL-04-001-Liver fibrosis revisited
17:15 - 18:45
PL-01 | Plenary OFP Session
PL-01-001-Expression of the inhibitory receptor CD94/NKG2A on CD8+ tumour-infiltrating lymphocytes in colorectal cancer: a new promising druggable immune checkpoint in a context of HLA-E/b2microglobuline overexpression by tumour cells
PL-01-002-Significant inter- and intra-laboratory variation in grading of invasive breast cancer: a nationwide study of 33,043 patients in the Netherlands
PL-01-003-A gene expression signature of microvascular invasion in hepatocellular carcinoma in formalin fixed-paraffin embedded biopsies
PL-01-006-Features of PLAP expression in placental structures during allogeniec pregnancy (surrogate maternity, oocyte donation) on the background of pre-eclampsia, as an indicator of exosomal trophoblast activity
PL-01-007-XIST promoter methylation status as putative molecular biomarker for testicular germ cell tumours
PL-01-008-Progenitor cells in ovario-fimbrial zone of female uterine adnexa: a potential clue for epithelial tumours pathogenesis